ELTX
Elicio Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.11 / 10
Netural
Fund-flow analysis shows a strong 7.46/10 score, with overall inflow ratio at 0.4196, suggesting buying interest persists despite negative block, small, medium, and large-scale trends. Analyst coverage is limited to one institution with a Strong Buy rating, and historical win rate is only 50%. Combined, the data hint at cautious optimism but insufficient conviction for aggressive positioning.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-07-17
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of ELTX?
- ELTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.11/10 (Netural).
